Skip to main content
Clinical Trials/NCT04814290
NCT04814290CompletedNot Applicable

Long-term Follow-up of Living Liver Donors: A Single-center Experience

Mansoura University0 sites476 target enrollmentStarted: May 1, 2004Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
476
Primary Endpoint
health-related quality of life (HRQoL)

Study Overview

Brief Summary

Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up.

Detailed Description

Data on the long-term consequences of living liver donation are scarce. This study examined clinical, laboratory, and radiological parameters and long-term health-related quality of life (HRQoL) in 237 living liver donors and 239 matched controls during 48 to 168 months of postdonation follow-up.

We used the 36-item short-form health survey (short form-36 health survey, version 1 [SF-36]). The scores for the 4 following subscales were higher in nondonors than in donors: physical functioning (P = 0.009), role limitations due to physical health (P = 0.002), energy/fatigue (P < 0.001), and bodily pain (P < 0.001). The scores on the 8 subscales of the SF-36 were higher in donors with living recipients than in donors whose recipients died (P < 0.001). Our results suggest that living donor right hepatectomy is safe and results in a postdonation HRQoL similar to that of nondonors in those donors whose recipients are healthy, while donors whose recipients die have a lower HRQoL that is significantly negatively correlated with the time since recipient death and improves over time.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •age 18-50 years
  • •no comorbidities.
  • •BMI less than 30 kg/m
  • •compatible ABO group.

Exclusion Criteria

  • •Older than 50 years.
  • •Associated comorbidities.
  • •Noncompatible ABO group.

Outcomes

Primary Outcomes

health-related quality of life (HRQoL)

Time Frame: 4 to 16 years of follow up

health-related quality of life (HRQoL) (36-item short-form health survey, version 1 \[SF-36\]).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Shehta

MD, PhD

Mansoura University

Similar Trials